Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients

Oncotarget

Volumn 6, Issue 29, 2015, Pages 27378-27387

  Wan, Fangning ^a,b   Wang, Hongkai ^a,b   Shen, Yijun ^a,b   Zhang, Hailiang ^a,b   Shi, Guohai ^a,b   Zhu, Yao ^a,b   Dai, Bo ^a,b   Ye, Dingwei ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Clear cell renal cell carcinoma; COL6A1; Prognosis; Tumorigenesis

Indexed keywords

COLLAGEN TYPE 6; COL6A1 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; COHORT ANALYSIS; COL6A1 GENE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NEPHRECTOMY; NEPHRON SPARING NEPHRECTOMY; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; RADICAL NEPHRECTOMY; RNA EXTRACTION; SURVIVAL RATE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KAPLAN MEIER METHOD; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUDE MOUSE; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOGENESIS; CARCINOMA, RENAL CELL; COHORT STUDIES; COLLAGEN TYPE VI; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM TRANSPLANTATION; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UP-REGULATION;

EID: 84944474392     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4860     Document Type: Article

References (23)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012; 62:10-29.
2. Ficarra V, Galfano A, Novara G, Iafrate M, Brunelli M, Secco S, Cavalleri S, Martignoni G, Artibani W. Risk stratification and prognostication of renal cell carcinoma. World journal of urology. 2008; 26:115-125.
3. Keene DR, Engvall E, Glanville RW. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J Cell Biol. 1988; 107:1995-2006.
4. Cheng IH, Lin YC, Hwang E, Huang HT, Chang WH, Liu YL, Chao CY. Collagen VI protects against neuronal apoptosis elicited by ultraviolet irradiation via an Akt/phosphatidylinositol 3-kinase signaling pathway. Neuroscience. 2011; 183:178-188.
5. Spencer M, Yao-Borengasser A, Unal R, Rasouli N, Gurley CM, Zhu B, Peterson CA, Kern PA. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. American journal of physiology Endocrinology and metabolism. 2010; 299:E1016-1027.
6. Park J, Scherer PE. Adipocyte-derived endotrophin promotes malignant tumor progression. The Journal of clinical investigation. 2012; 122:4243-4256.
7. Chiu KH, Chang YH, Wu YS, Lee SH, Liao PC. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling. Journal of proteome research. 2011; 10:1110-1125.
8. Blanco MA, LeRoy G, Khan Z, Aleckovic M, Zee BM, Garcia BA, Kang Y. Global secretome analysis identifies novel mediators of bone metastasis. Cell research. 2012; 22:1339-1355.
9. Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014; 15:786-801.
10. Jimenez-Mallebrera C, Brown SC, Sewry CA, Muntoni F. Congenital muscular dystrophy: molecular and cellular aspects. Cellular and molecular life sciences: CMLS. 2005; 62:809-823.
11. Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta P, Columbaro M, Volpin D, Bressan GM, Bernardi P, Bonaldo P. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nature genetics. 2003; 35:367-371.
12. Ishikawa H, Sugie K, Murayama K, Ito M, Minami N, Nishino I, Nonaka I. Ullrich disease: collagen VI deficiency: EM suggests a new basis for muscular weakness. Neurology. 2002; 59:920-923.
13. Fujita A, Sato JR, Festa F, Gomes LR, Oba-Shinjo SM, Marie SK, Ferreira CE, Sogayar MC. Identification of COL6A1 as a differentially expressed gene in human astrocytomas. Genetics and molecular research: GMR. 2008; 7:371-378.
14. Fitzgerald J, Rich C, Zhou F, Hansen U. Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). The Journal of biological chemistry. 2008; 283:20170-20180.
15. Niu X, Zhang T, Liao L, Zhou L, Lindner D, Zhou M, Rini B, Yan Q, Yang H. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene. 2012; 31:776-786.
16. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. The Journal of biological chemistry. 2001; 276:17058-17062.
17. Chen YL, Lv J, Ye XL, Sun MY, Xu Q, Liu CH, Min LH, Li HP, Liu P, Ding X. Sorafenib inhibits transforming growth factor beta1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology. 2011; 53:1708-1718.
18. Elsner A, Lange F, Fitzner B, Heuschkel M, Krause BJ, Jaster R. Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells. World journal of gastroenterology: WJG. 2014; 20:7914-7925.
19. Jiang YZ, Yu KD, Zuo WJ, Peng WT, Shao ZM. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival. Cancer. 2014; 120:1329-1337.
20. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene. 2009; 28:4065-4074.
21. Zhu YP, Wan FN, Shen YJ, Wang HK, Zhang GM, Ye DW. Reactive stroma component COLA1 is upregulated in castration-resistant prostate cancer and promotes tumor growth. Oncotarget. 2015; 6:14488-14496.
22. Swindle CS, Kim HG, Klug CA. Mutation of CpGs in the murine stem cell virus retroviral vector long terminal repeat represses silencing in embryonic stem cells. The Journal of biological chemistry. 2004; 279:34-41.
23. Choi JK, Hoang N, Vilardi AM, Conrad P, Emerson SG, Gewirtz AM. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells. Stem Cells. 2001; 19:236-246.